An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 3 OPTIMIZE trial met both primary efficacy ...

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...

Please provide your email address to receive an email when new articles are posted on . A novel preservative-free betamethasone eye drop formulation showed efficacy in preventing inflammation and pain ...

This outpatient procedure is a safe and effective way to improve your vision—and many patients say it’s life-changing.

OPTIMIZE (Once-daily Post-ocular surgery Treatment for InflaMmation and paIn to minimiZE drops) is a double-blind, placebo-controlled Phase 3 trial conducted in 25 sites across the US with 241 ...

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...

This article was originally featured on The Conversation. Cataract surgery is one of the most popular and commonly performed procedures in the world. The vast majority of patients have excellent ...

Steven Reed, OD, is a board-certified optometrist and president of the American Optometric Association. With over 25 years of experience, Dr. Reed has also served as past president of the Mississippi ...

Every year, nearly 700,000 people in England have cataracts removed, making it one of the most common ops in the country. The procedure, which replaces the eye’s lens after it grows cloudy over time, ...